H00057728-B01P
antibody from Abnova Corporation
Targeting: WDR19
DYF-2, FAP66, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- H00057728-B01P - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#H00057728-B01P, RRID:AB_1581909
- Product name
- WDR19 purified MaxPab mouse polyclonal antibody (B01P)
- Antibody type
- Polyclonal
- Description
- Mouse polyclonal antibody raised against a full-length human WDR19 protein.
- Antigen sequence
MKRIFSLLEKTWLGAPIQFAWQKTSGNYLAVTGAD
YIVKIFDRHGQKRSEINLPGNCVAMDWDKDGDVLA
VIAEKSSCIYLWDANTNKTSQLDNGMRDQMSFLLW
SKVGSFLAVGTVKGNLLIYNHQTSRKIPVLGKHTK
RITCGCWNAENLLALGGEDKMITVSNQEGDTIRQT
QVRSEPSNMQFFLMKMDDRTSAAESMISVVLGKKT
LFFLNLNEPDNPADLEFQQDFGNIVCYNWYGDGRI
MIGFSCGHFVVISTHTGELGQEIFQARNHKDNLTS
IAVSQTLNKVATCGDNCIKIQDLVDLKDMYVILNL
DEENKGLGTLSWTDDGQLLALSTQRGSLHVFLTKL
PILGDACSTRIAYLTSLLEVTVANPVEGELPITVS
VDVEPNFVAVGLYHLAVGMNNRAWFYVLGENAVKK
IERYGVSGNSSQYLPSF- Storage
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Submitted references ICK is essential for cell type-specific ciliogenesis and the regulation of ciliary transport.
Mutations in mouse Ift144 model the craniofacial, limb and rib defects in skeletal ciliopathies.
Ciliopathies with skeletal anomalies and renal insufficiency due to mutations in the IFT-A gene WDR19.
Chaya T, Omori Y, Kuwahara R, Furukawa T
The EMBO journal 2014 Jun 2;33(11):1227-42
The EMBO journal 2014 Jun 2;33(11):1227-42
Mutations in mouse Ift144 model the craniofacial, limb and rib defects in skeletal ciliopathies.
Ashe A, Butterfield NC, Town L, Courtney AD, Cooper AN, Ferguson C, Barry R, Olsson F, Liem KF Jr, Parton RG, Wainwright BJ, Anderson KV, Whitelaw E, Wicking C
Human molecular genetics 2012 Apr 15;21(8):1808-23
Human molecular genetics 2012 Apr 15;21(8):1808-23
Ciliopathies with skeletal anomalies and renal insufficiency due to mutations in the IFT-A gene WDR19.
Bredrup C, Saunier S, Oud MM, Fiskerstrand T, Hoischen A, Brackman D, Leh SM, Midtbø M, Filhol E, Bole-Feysot C, Nitschké P, Gilissen C, Haugen OH, Sanders JS, Stolte-Dijkstra I, Mans DA, Steenbergen EJ, Hamel BC, Matignon M, Pfundt R, Jeanpierre C, Boman H, Rødahl E, Veltman JA, Knappskog PM, Knoers NV, Roepman R, Arts HH
American journal of human genetics 2011 Nov 11;89(5):634-43
American journal of human genetics 2011 Nov 11;89(5):634-43
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western Blot analysis of WDR19 expression in transfected 293T cell line by WDR19 MaxPab polyclonal antibody.Lane 1: WDR19 transfected lysate(48.07 KDa).Lane 2: Non-transfected lysate.